← All companies

MRNA

Moderna, Inc.

MRNA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$57.65

+0.66 +1.16%

Key statistics

from XBRL data in SEC filings

Market cap

$23.0B

Revenue (TTM)

$2.23B

Net income (TTM)

-$3.15B

EPS (TTM)

$-7.98

P/E ratio

—

Dividend yield

—

Free cash flow

-$2.06B

Cash

$1.72B

Total assets

$11.0B

Gross margin

—

52-week range

$22.28 – $85.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 31, 2026 8-K Results of operations (earnings release) Jul 31, 2026 8-K Director or officer change; Regulation FD disclosure Jul 8, 2026 8-K Amended charter or bylaws; Shareholder vote results May 11, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Results of operations (earnings release) May 1, 2026 8-K Entered a material agreement Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 20, 2026 8-K Results of operations (earnings release) Feb 13, 2026 8-K Regulation FD disclosure; Other events Feb 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Regulation FD disclosure Jan 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation Nov 24, 2025 8-K Regulation FD disclosure Nov 20, 2025 8-K Shareholder vote results Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 1, 2025 8-K Results of operations (earnings release) Aug 1, 2025 8-K Shareholder vote results May 5, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) May 1, 2025 10-K Fiscal year ended 2024-12-31 Feb 21, 2025 8-K Results of operations (earnings release) Feb 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Director or officer change; Regulation FD disclosure Oct 2, 2024 8-K Regulation FD disclosure Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Director or officer change; Regulation FD disclosure Jul 23, 2024 8-K Amended charter or bylaws; Shareholder vote results May 9, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 23, 2024 8-K Results of operations (earnings release) Feb 22, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 8-K Director or officer change Dec 12, 2023 8-K Regulation FD disclosure Nov 6, 2023